DETERMINATION OF DICLOFENAC SODIUM IN RABBIT PLASMA BY HPLC/UV: EVALUATION AND CHARACTERIZATION OF ITS CRYSTALLINE FORMS, ANHYDROUS AND HYDRATE, ON THE ANTIPYRETIC EFFECT

REFERENCES

• Kenny , J. R. ; Maggs , J. L. ; Meng , X. ; Sinnott , D. ; Clarke , S. E. ; Park , B. K. ; Stachulski , A. V. Syntheses and Characterization of the Acyl Glucuronide and Hydroxy Metabolites of Diclofenac . J. Med. Chem. 2004 , 47 , 2816 – 2825 .
   PubMed Web of Science ®Google Scholar
• Tagirova , D. R. ; Mukhutdinova , F. I. Effect of Sodium Diclofenac on Microcirculation and Composition of the Lymph during Fever Reaction. General Pathology and Pathophysiology . Bull. Exper. Biol. Med. 2005 , 139 , 264 – 266 .
   Google Scholar
• Hawkey , C. J. COX-2 Inhibitors . The Lancet 1999 , 353 , 307 – 314 .
   PubMed Web of Science ®Google Scholar
• Murakami , M. ; Kambe , T. ; Shimbara , S. ; Kudo , I. Functional Coupling Between Various Phospholipase A2s and Cyclooxygenases in Immediate and Delayed Prostanoid Biosynthetic Pathways . J. Biol. Chem. 1999 , 274 , 3103 – 3115 .
   PubMed Web of Science ®Google Scholar
• Funk , C. D. ; FitzGerald , G. A. COX-2 Inhibitors and Cardiovascular Risk. J. Cardiovasc. Pharm. 2007, 50, 470–479.
   PubMed Web of Science ®Google Scholar
• Marwali , M. R. ; Mehta , J. L. COX-2 Inhibitors and Cardiovascular Risk . Thromb. Haemost. 2006 , 96 , 401 – 406 .
   PubMed Web of Science ®Google Scholar
• McGettigan , P. ; Henry , D. Cardiovascular Risk and Inhibition of Cyclooxygenase . J. Americ. Med. Assoc. 2006 , 296 , 1633 – 1644 .
   PubMed Web of Science ®Google Scholar
• Lucena , M. I. ; Camargo , R. ; Andrade , R. J. ; Perez-Sanchez , C. J. ; Sanchez , C. F. Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity . Hepatology. 2001 , 33 , 123 – 130 .
   PubMed Web of Science ®Google Scholar
• Bartolomei , M. ; Bertocchi , P. ; Antoniella , E. ; Rodomonte , A. Physico-Chemical Characterization and Intrinsic Dissolution Studies of a New Hydrate Form of Diclofenac Sodium: Comparison with Anhydrous Form . J. Pharm. Biomed. Anal. 2006 , 40 , 1105 – 1113 .
   PubMed Web of Science ®Google Scholar
• Giagoudakis , G. ; Markantonis , S. L. An Alternative High-Performance Liquid-Chromatographic Method for the Determination of Diclofenaco and Flurbiprofen in Plasma . J. Pharm. Biomed. Anal. 199 , 17 , 897 – 901 .
   Google Scholar
• Muller , C. P. ; Hass , S. E. ; Bassini , V. L. ; Guterres , S. S. Degradação e Estabilização do Diclofenaco em nanocapsulas poliméricas . Quím. Nova. 2004 , 27 , 555 – 560 .
   Web of Science ®Google Scholar
• Kaphalia , L. ; Kaphalia , B. S. ; Kumar , S. ; Kang , M. F. ; Treinen-Moslen , M. Efficient High Performance Liquid-Chromatography/Ultraviolet Method for Determination of Diclofenac and 4′-Hydroxydiclofenac in Rat Serum . J. Chromatogr. B. 2006 , 830 , 231 – 237 .
   PubMed Web of Science ®Google Scholar
• Bartolomei , M. ; Rodomonte , A. ; Antoniella , E. ; Minelli , G. ; Bertocchi , P. Hydrate Modifications of the Non-Steroidal Anti-Inflammatory Drug Diclofenac Sodium: Solid-State Characterization of a Trihydrate Form . J. Pharm. Biomed. Anal. 2007 , 45 , 443 – 449 .
   PubMed Web of Science ®Google Scholar
• Santos , J. L. ; Aparicio , I. ; Alonso , E. Occurrence and Risk Assessment of Pharmaceutically Active Compounds in Wastewater Treatment Plants. A Case Study: Seville City (Spain) . Environ. Int. 2007 , 33 , 596 – 601 .
   PubMed Web of Science ®Google Scholar
• Burke , A. ; Smyth , E. ; Fitzgerald , G. A. Analgesic-Antipyretic and Antiinflammatory Agents; Pharmacotherapy of Gout . In Pharmacological Basis of Therapeutics ; Brunton , L. L. ; Lazo , J. S. ; Parker , K. L. A. , Eds.; McGraw-Hill : São Paulo , 2006 , pp 601 – 638 .
   Google Scholar
• Castro , W. V. ; Pires , M. A. S. ; Oliveira , M. A. ; Vianna-Soares , C. D. ; Nunan , E. A. ; Pianetti , G. A. ; Moreira-Campos , L. M. ; Mertens-Talcott , S. U. ; Derendorf , H. The Influence of Formulation on the Dissolution Profile of Diclofenac Sodium Tablets . Drug Dev. Ind. Pharm. 2006 , 32 , 1103 – 1109 .
   PubMed Web of Science ®Google Scholar
• Dressman , J. B. ; Amidon , G. L. ; Reppas , C. ; Shah , V. P. Dissolution Testing as a Prognostics Tool for Oral Absorption Immediate Dosage Forms . Pharm. Res. 1998 , 15 , 11 – 22 .
   PubMed Web of Science ®Google Scholar
• Brittain , H. G. Polymorphism and Solvatomorphism 2007 . J. Pharm. Sci. 2008 , 97 , 3611 – 3636 .
   PubMed Web of Science ®Google Scholar
• Vippagunta , S. R. ; Brittain , H. G. ; Grant , D. J. W. Crystalline Solids . Adv. Drug Deliv. Rev. 2001 , 48 , 3 – 26 .
   PubMed Web of Science ®Google Scholar
• Agatonovic-Kustrin , S. ; Rades , T. ; Wu , V. ; Saville , D. ; Tucker , I. G. Determination of Polymorphic Forms of Ranitidine–HCl by DRIFTS and XRPD . J. Pharm. Biomed. Anal. 2001 , 25 , 741 – 750 .
   PubMed Web of Science ®Google Scholar
• Zhang , G. G. Z. ; Law , D. ; Schmitt , E. A. ; Yihong , Q. Phase Transformation Considerations During Process Development and Manufacture of Solid Oral Dosage Forms . Adv. Drug Deliv. Rev. 2004 , 56 , 371 – 390 .
   PubMed Web of Science ®Google Scholar
• Storpirtis , S. Biofarmacotécnica: fundamentos de biodisponibilidade, bioequivalência, dissolução e intercambialidade de medicamentos genéricos. ed. USP: São Paulo, 1999, p. 78.
   Google Scholar
• Zimmermann , B. ; Baranovíc , G. Thermal Analysis of Paracetamol Polymorphs by FT-IR Spectroscopies . J. Pharm. Biomed. Anal. 2011 , 54 , 295 – 302 .
   PubMed Web of Science ®Google Scholar
• Limandri , S. ; Visñovezky , C. ; Pérez , S. ; Schurrer , C. ; Ferro , M. ; de Souza , J. G. ; Aguiar , F. A. ; de Gaitani , C. M. ; Cuffini , S. L. ; Wolfenson , A. NQR: A Technique to Control Hydration Processes in the Pharmaceutical Industry . Anal. Chem. 2011 , 83 , 1773 – 1776 .
   PubMed Web of Science ®Google Scholar
• Brittain , H. G. ; Fiese , E. F. 1999 . Effects of Pharmaceutical Processing on Drug Polymorphs and Solvates . In Polymorphism in Pharmaceutical Solids ; Brittain , H. G. , Ed.; Marcel Dekker , New York , 1999 , pp 331 – 361 .
   Google Scholar
• FDA Guidance for Industry: Bioanalytical Method Validation; Center for Drug Evaluation and Research: Rockville, 2001. Available at: http://www.fda.gov/cder/guidance/index.htm (accessed in 2010) .
   Google Scholar
• Zimmermann , M. Ethical Guidelines for Investigations of Experimental Pain in Conscious Animals . Pain. 1983 , 16 , 109 – 110 .
   PubMed Web of Science ®Google Scholar
• Giron , D. Thermal Analysis and Calorimetric Methods in the Characterization of Polymorphs and Solvates. Thermochim. Acta. 1995, 248, l–59.
   Web of Science ®Google Scholar
• Llinàs , A. ; Burley , J. C. ; Box , K. J. ; Glen , R. C. ; Goodman , J. M. Diclofenac Solubility: Independent Determination of the Intrinsic Solubility of Three Crystal Forms . J. Med. Chem. 2007 , 50 , 979 – 983 .
   PubMed Web of Science ®Google Scholar
• Fini , A. ; Garuti , M. ; Fazio , G. ; Alvarez-Fuentes , J. ; Holgado , M. A. Diclofenac Salts. I. Fractal and Thermal Analysis of Sodium and Potassium Diclofenac Salts . J. Pharm. Sci. 2001 , 90 , 2049 – 2057 .
   PubMed Web of Science ®Google Scholar
• Fini , A. ; Fazio , G. ; Rosetti , F. ; Holgado , M. A. ; Iruín , A. ; Alvarez-Fuentes , J. Diclofenac Salts. III. Alkaline and Earth Alkaline Salts . J. Pharm. Sci. 2005 , 94 , 2416 – 2431 .
   PubMed Web of Science ®Google Scholar
• Palomo , M. E. ; Ballesteros , M. P. ; Frutos , P. Analysis of Diclofenac Sodium and Derivatives . J. Pharm. Biomed. Anal. 1999 , 21 , 83 – 94 .
   PubMed Web of Science ®Google Scholar
• Chmielewska , A. ; Konieczna , L. ; Plenis , A. ; Bieniecki , M. ; Lamparczyk , H. Determination of Diclofenac in Plasma by High Performance Liquid-Chromatography with Electrochemical Detection . Biomed. Chromatogr. 2006 , 20 , 119 – 124 .
   PubMed Web of Science ®Google Scholar
• Dorado , P. ; Berecz , R. ; Caceres , M. C. ; Llerena , A. Analysis of Diclofenac and Its Metabolites by High-Performance Liquid Chromatography: Relevance of CYP2C9 Genotypes in Diclofenac Urinary Metabolic Ratios . J. Chromatogr. B. 2003 , 789 , 437 – 442 .
   PubMed Web of Science ®Google Scholar
• Causon , R. Validation of Chromatographic Methods in Biomedical Analysis Viewpoint and Discussion . J. Chromatogr. B. 1997 , 689 , 175 – 180 .
   PubMed Web of Science ®Google Scholar
• Hartmann , C. ; Smeyers-Verbeke , J. ; Massart , D. L. ; Mcdowall , R. D. Validation of Bioanalytical Chromatographic Methods . J. Pharm. Biomed. Anal. 1998 , 17 , 193 – 218 .
   PubMed Web of Science ®Google Scholar
• Shah , V. P. ; Midha , K. K. ; Findlay , J. W. A. ; Hill , H. M. ; Hulse , J. D. ; Mcgilveray , I. J. ; Mckay , G. ; Miller , K. J. ; Patnaik , R. N. ; Powell , M. L. ; Tonelli , A. ; Viswanathan , C. T. ; Yacobi , A. Bionalytical Method Validation–A Revisit with a Decade of Progress . Pharm. Res. 2000 , 17 , 1551 – 1557 .
   PubMedGoogle Scholar
• Lee , H. S. ; Jeong , C. K. ; Choi , S. J. ; Kim , S. B. ; Lee , M. H. ; Ko , G. I. ; Sohn , D. H. Simultaneous Determination of Aceclofenac and Diclofenac in Human Plasma by Narrowbore HPLC Using Column-Switching . J. Pharm. Biomed. Anal. 2000 , 23 , 775 – 781 .
   PubMed Web of Science ®Google Scholar
• Arcelloni , C. ; Lanzi , R. ; Pedercini , S. ; Molteni , G. ; Fermo , I. ; Pontiroli , A. ; Paroni , R. High-Performance Liquid Chromatographic Determination of Diclofenac in Human Plasma After Solid-Phase Extraction . J. Chromatogr. B.: Biomed. Sci. Appl. 2000 , 763 , 195 – 200 .
   Google Scholar
• Jiao , H. ; Xu , F. ; Zhang , Z. ; Tian , Y. ; Jiang , Z. ; Zhang , L. Simultaneous Determination of ZLR-8 and Its Active Metabolite Diclofenac in Dog Plasma by High-Performance Liquid Chromatography . Biomed. Chromatogr. 2007 , 21 , 382 – 388 .
   PubMed Web of Science ®Google Scholar
• Venho , V. M. K. ; Eriksson , H. The Rabbit: An Animal Model for Comparative Bioavailability Studies of Drugs . Int. J. Pharm. 1986 , 30 , 91 – 94 .
   Web of Science ®Google Scholar
• Lala , L. G. ; D'Mello , P. M. ; Naik , S. R. Pharmacokinetic and Pharmacodynamic Studies on Interaction of “Trikatu” with Diclofenac Sodium . J. Ethnopharm. 2004 , 91 , 277 – 280 .
   PubMed Web of Science ®Google Scholar
• Roth , J. ; Souza , G. E. P. Fever Induction Pathways: Evidence from Responses to Systemic or Local Cytokine Formation . Braz. J. Med. Biol. Res. 2001 , 34 , 301 – 314 .
   PubMed Web of Science ®Google Scholar
• Nakamura , K. ; Matsumura , K. ; Kobayashi , S. ; Kaneko , T. Sympathetic Premotor Neurons Mediating Thermoregulatory Functions . Neurosci. Res. 2005 , 51 , 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Lazarus , M. ; Yoshida , K. ; Coppari , R. ; Bass , C. E. ; Mochizuki , T. ; Lowell , B. B. ; Saper , C. B. EP3 Prostaglandin Receptors in the Median Preoptic Nucleus are Critical for Fever Responses . Nat. Neurosci. 2007 , 10 , 1131 – 1133 .
   PubMed Web of Science ®Google Scholar
• Fabricio , A. S. C. ; Rae , G. A. ; D'orleans-Juste , P. ; Souza , G. E. Endothelin-1 as a Central Mediator of LPS-Induced Fever in Rats . Brain Res. 2005 , 1066 , 92 – 100 .
   PubMed Web of Science ®Google Scholar
• Huang , W. T. ; Niu , K. C. ; Chang , C. K. ; Lin , M. T. ; Chang , C. P. Curcumin Inhibits the Increase of Glutamate, Hydroxyl Radicals and PGE2 in the Hypothalamus and Reduces Fever During LPS-Induced Systemic Inflammation in Rabbits . Eur. J. Pharmacol. 2008 , 593 , 105 – 111 .
   PubMed Web of Science ®Google Scholar
• Blatteis , C. M. Endotoxic Fever: New Concepts of Its Regulation Suggest New Approaches to Its Management . Pharmacol. Ther. 2006 , 111 , 194 – 223 .
   PubMed Web of Science ®Google Scholar
• Roth , J. Endogenous Antipyretics . Clin. Chim. Acta. 2006 , 371 , 13 – 24 .
   PubMed Web of Science ®Google Scholar
• Ross , G. ; Hübschle , T. ; Pehl , U. ; Braun , H. A. ; Voigt , K. ; Gerstberger , R. ; Roth , J. Fever Induction by Localized Subcutaneous Inflammation in Guinea Pigs: The Role of Cytokines and Prostaglandins . J. Appl. Physiol. 2003 , 94 , 1395 – 1402 .
   PubMed Web of Science ®Google Scholar